Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model

Beneficial Microbes

Volumn 9, Issue 3, 2018, Pages 495-513

  Libbey, J E ^a   Sanchez, J M ^a   Doty, D J ^a   Sim, J T ^a   Cusick, M F ^a,c   Cox, J E ^a   Fischer, K F ^a,b   Round, J L ^a   Fujinami, R S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b uBiota LLC   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Experimental autoimmune encephalomyelitis; Metabolomics; Microbiome; Myelin oligodendrocyte glycoprotein

Indexed keywords

SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDACEAE; BACTEROIDES; BLOOD ANALYSIS; BODY WEIGHT LOSS; CENTRAL NERVOUS SYSTEM; CITRIC ACID CYCLE; CONTROLLED STUDY; DIET; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FECES ANALYSIS; GLYCOLYSIS; IN VIVO STUDY; INCIDENCE; INTESTINE FLORA; LACTOBACILLUS; MALE; METABOLITE; METABOLOMICS; MICROFLORA; MOUSE; MULTIPLE SCLEROSIS; MUS MUSCULUS; NONHUMAN; RODENT; RUMINOCOCCACEAE; RUMINOCOCCUS; SCORING SYSTEM; THEILER'S MURINE ENCEPHALOMYELITIS VIRUS; ANIMAL; BODY WEIGHT; CHEMISTRY; DIET THERAPY; DISEASE MODEL; FECES; ISOLATION AND PURIFICATION; LACTOBACILLUS PARACASEI; METABOLOME; MICROBIOLOGY; PATHOLOGY; PROCEDURES; SERUM; SEVERITY OF ILLNESS INDEX;

ANIMALS; BODY WEIGHT; CITRIC ACID CYCLE; DIET THERAPY; DISEASE MODELS, ANIMAL; FECES; GASTROINTESTINAL MICROBIOME; GLYCOLYSIS; LACTOBACILLUS PARACASEI; METABOLOME; MICE; MULTIPLE SCLEROSIS; SERUM; SEVERITY OF ILLNESS INDEX;

EID: 85045138771     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2017.0116     Document Type: Article

References (43)

1. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., Wekerle, H. and Krishnamoorthy, G., 2011. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479: 538-541.
2. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., McDonald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Turnbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J. and Knight, R., 2010. QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7: 335-336.
3. Chen, J., Chia, N., Kalari, K.R., Yao, J.Z., Novotna, M., Soldan, M.M., Luckey, D.H., Marietta, E.V., Jeraldo, P.R., Chen, X., Weinshenker, B.G., Rodriguez, M., Kantarci, O.H., Nelson, H., Murray, J.A. and Mangalam, A.K., 2016. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Scientific Reports 6: 28484.
4. Choi, I.Y., Piccio, L., Childress, P., Bollman, B., Ghosh, A., Brandhorst, S., Suarez, J., Michalsen, A., Cross, A.H., Morgan, T.E., Wei, M., Paul, F., Bock, M. and Longo, V.D., 2016. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Reports 15: 2136-2146.
5. Colpitts, S.L., Kasper, E.J., Keever, A., Liljenberg, C., Kirby, T., Magori, K., Kasper, L.H. and Ochoa-Reparaz, J., 2017. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis. Gut Microbes 8: 561-573.
6. Goverman, J., Woods, A., Larson, L., Weiner, L.P., Hood, L. and Zaller, D.M., 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-560.
7. Haghikia, A., Jorg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.H., May, C., Wilck, N., Balogh, A., Ostermann, A.I., Schebb, N.H., Akkad, D.A., Grohme, D.A., Kleinewietfeld, M., Kempa, S., Thone, J., Demir, S., Muller, D.N., Gold, R. and Linker, R.A., 2015. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43: 817-829.
8. Hintze, K.J., Cox, J.E., Rompato, G., Benninghoff, A.D., Ward, R.E., Broadbent, J. and Lefevre, M., 2014. Broad scope method for creating humanized animal models for animal health and disease research through antibiotic treatment and human fecal transfer. Gut Microbes 5: 183-191.
9. Holmes, E., Li, J.V., Athanasiou, T., Ashrafian, H. and Nicholson, J.K., 2011. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends in Microbiology 19: 349-359.
10. Hooper, L.V., Littman, D.R. and Macpherson, A.J., 2012. Interactions between the microbiota and the immune system. Science 336: 1268-1273.
11. Ivanov, II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V., Tanoue, T., Imaoka, A., Itoh, K., Takeda, K., Umesaki, Y., Honda, K. and Littman, D.R., 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498.
12. Ivanov, II, Frutos, R.L., Manel, N., Yoshinaga, K., Rifkin, D.B., Sartor, R.B., Finlay, B.B. and Littman, D.R., 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host and Microbe 4: 337-349.
13. Jangi, S., Gandhi, R., Cox, L.M., Li, N., Von Glehn, F., Yan, R., Patel, B., Mazzola, M.A., Liu, S., Glanz, B.L., Cook, S., Tankou, S., Stuart, F., Melo, K., Nejad, P., Smith, K., Topcuolu, B.D., Holden, J., Kivisakk, P., Chitnis, T., De Jager, P.L., Quintana, F.J., Gerber, G.K., Bry, L. and Weiner, H.L., 2016. Alterations of the human gut microbiome in multiple sclerosis. Nature Communications 7: 12015.
14. Kobayashi, T., Kato, I., Nanno, M., Shida, K., Shibuya, K., Matsuoka, Y. and Onoue, M., 2010. Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacology and Immunotoxicology 32: 116-124.
15. Kubinak, J.L., Petersen, C., Stephens, W.Z., Soto, R., Bake, E., O'Connell, R.M. and Round, J.L., 2015. MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host and Microbe 17: 153-163.
16. Kwon, H.K., Kim, G.C., Kim, Y., Hwang, W., Jash, A., Sahoo, A., Kim, J.E., Nam, J.H. and Im, S.H., 2013. Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response. Clinical Immunology 146: 217-227.
17. Lavasani, S., Dzhambazov, B., Nouri, M., Fak, F., Buske, S., Molin, G., Thorlacius, H., Alenfall, J., Jeppsson, B. and Westrom, B., 2010. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 5: e9009.
18. Lee, Y.K., Menezes, J.S., Umesaki, Y. and Mazmanian, S.K., 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the USA 108, Suppl. 1: 4615-4622.
19. Leinonen, R., Sugawara, H. and Shumway, M., 2011. The sequence read archive. Nucleic Acids Research 39: D19-21.
20. Ley, R.E., Turnbaugh, P.J., Klein, S. and Gordon, J.I., 2006. Human gut microbes associated with obesity. Nature 444: 1022-1023.
21. Libbey, J.E., Doty, D.J., Sim, J.T., Cusick, M.F., Round, J.L. and Fujinami, R.S., 2016. The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability. Nutrition 32: 877-883.
22. Lochner, M., Berod, L. and Sparwasser, T., 2015. Fatty acid metabolism in the regulation of T cell function. Trends in Immunology 36: 81-91.
23. Louis, P., Scott, K.P., Duncan, S.H. and Flint, H.J., 2007. Understanding the effects of diet on bacterial metabolism in the large intestine. Journal of Applied Microbiology 102: 1197-1208.
24. Maassen, C.B. and Claassen, E., 2008. Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity. Vaccine 26: 2056-2057.
25. Maassen, C.B., Laman, J.D., Van Holten-Neelen, C., Hoogteijling, L., Groenewegen, L., Visser, L., Schellekens, M.M., Boersma, W.J. and Claassen, E., 2003. Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens. Vaccine 21: 4685-4693.
26. Masella, A.P., Bartram, A.K., Truszkowski, J.M., Brown, D.G. and Neufeld, J.D., 2012. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics 13: 31.
27. Mathur, D., Lopez-Rodas, G., Casanova, B. and Marti, M.B., 2014. Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis. Frontiers in Neurology 5: 250.
28. Miyake, S., Kim, S., Suda, W., Oshima, K., Nakamura, M., Matsuoka, T., Chihara, N., Tomita, A., Sato, W., Kim, S.W., Morita, H., Hattori, M. and Yamamura, T., 2015. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE 10: e0137429.
29. Ochoa-Reparaz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Begum-Haque, S., Dasgupta, S., Kasper, D.L. and Kasper, L.H., 2010. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. Journal of Immunology 185: 4101-4108.
30. Ochoa-Reparaz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Foureau, D.M., Haque-Begum, S. and Kasper, L.H., 2009. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. Journal of Immunology 183: 6041-6050.
31. Rooks, M.G. and Garrett, W.S., 2016. Gut microbiota, metabolites and host immunity. Nature reviews. Immunology 16: 341-352.
32. Rothhammer, V. and Quintana, F.J., 2016. Environmental control of autoimmune inflammation in the central nervous system. Current Opinion in Immunology 43: 46-53.
33. Shi, L.Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D.R. and Chi, H., 2011. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. Journal of Experimental Medicine 208: 1367-1376.
34. Sonnenburg, E.D., Zheng, H., Joglekar, P., Higginbottom, S.K., Firbank, S.J., Bolam, D.N. and Sonnenburg, J.L., 2010. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141: 1241-1252.
35. Tremlett, H., Bauer, K.C., Appel-Cresswell, S., Finlay, B.B. and Waubant, E., 2017. The gut microbiome in human neurological disease: a review. Annals of Neurology 81: 369-382.
36. Tremlett, H., Fadrosh, D.W., Faruqi, A.A., Zhu, F., Hart, J., Roalstad, S., Graves, J., Lynch, S. and Waubant, E., 2016. Gut microbiota in early pediatric multiple sclerosis: a case-control study. European Journal of Neurology 23: 1308-1321.
37. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R. and Gordon, J.I., 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
38. Wahl, D.R., Byersdorfer, C.A., Ferrara, J.L., Opipari Jr., A.W. and Glick, G.D., 2012. Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation. Immunological Reviews 249: 104-115.
39. Walter, J., 2008. Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Applied and Environmental Microbiology 74: 4985-4996.
40. Wang, Y. and Kasper, L.H., 2014. The role of microbiome in central nervous system disorders. Brain, Behavior, and Immunity 38: 1-12.
41. Wekerle, H., 2016. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology 55: ii68-ii75.
42. Winkelmann, A., Loebermann, M., Reisinger, E.C., Hartung, H.P. and Zettl, U.K., 2016. Disease-modifying therapies and infectious risks in multiple sclerosis. Nature reviews. Neurology 12: 217-233.
43. Yokote, H., Miyake, S., Croxford, J.L., Oki, S., Mizusawa, H. and Yamamura, T., 2008. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. American Journal of Pathology 173: 1714-1723.